Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2282)
All Articles published online
|
Sep 14, 2009 (publication date) through Jun 4, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ghiringhelli F, Guiu B, Chauffert B, Ladoire S. Sirolimus, bevacizumab, 5-Fluorouracil and irinotecan for advanced colorectal cancer: A pilot study. World J Gastroenterol 2009; 15(34): 4278-4283 [PMID: 19750570 DOI: 10.3748/wjg.15.4278] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i34/4278.htm |
| Number | Citing Articles |
| 1 |
Melissa Hu, Oleksandr Ekshyyan, Lilantha Herman Ferdinandez, Xiaohua Rong, Gloria Caldito, Cherie‐Ann O. Nathan. Efficacy and comparative effectiveness of sirolimus as an anticancer drug. The Laryngoscope 2011; 121(5): 978 doi: 10.1002/lary.21724
|
| 2 |
Sarah Jannier, Véronique Kemmel, Consuelo Sebastia Sancho, Agathe Chammas, Amelia-Naomie Sabo, Erwan Pencreach, Françoise Farace, Marie Pierre Chenard, Benoit Lhermitte, Birgit Geoerger, Isabelle Aerts, Didier Frappaz, Pierre Leblond, Nicolas André, Stephane Ducassou, Nadège Corradini, Anne Isabelle Bertozzi, Eric Guérin, Florence Vincent, Michel Velten, Natacha Entz-Werle. SFCE-RAPIRI Phase I Study of Rapamycin Plus Irinotecan: A New Way to Target Intra-Tumor Hypoxia in Pediatric Refractory Cancers. Cancers 2020; 12(10): 3051 doi: 10.3390/cancers12103051
|